X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16533) 16533
Publication (1410) 1410
Newsletter (198) 198
Book Review (190) 190
Book Chapter (52) 52
Magazine Article (51) 51
Conference Proceeding (40) 40
Newspaper Article (18) 18
Book / eBook (17) 17
Government Document (11) 11
Dissertation (9) 9
Web Resource (8) 8
Trade Publication Article (5) 5
Presentation (4) 4
Report (2) 2
Streaming Video (2) 2
Transcript (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13921) 13921
female (12637) 12637
tamoxifen (9044) 9044
tamoxifen - therapeutic use (8022) 8022
breast neoplasms - drug therapy (7862) 7862
oncology (6674) 6674
breast cancer (6110) 6110
middle aged (5713) 5713
index medicus (5706) 5706
aged (4375) 4375
antineoplastic agents, hormonal - therapeutic use (4008) 4008
adult (3820) 3820
breast neoplasms - pathology (3332) 3332
cancer (3135) 3135
postmenopausal women (2659) 2659
animals (2546) 2546
estrogen (2137) 2137
antineoplastic combined chemotherapy protocols - therapeutic use (2126) 2126
treatment outcome (2000) 2000
chemotherapy, adjuvant (1998) 1998
tamoxifen - pharmacology (1964) 1964
breast neoplasms - metabolism (1889) 1889
chemotherapy (1873) 1873
care and treatment (1855) 1855
therapy (1845) 1845
tamoxifen - administration & dosage (1802) 1802
tamoxifen - adverse effects (1734) 1734
male (1726) 1726
prognosis (1709) 1709
women (1641) 1641
aged, 80 and over (1541) 1541
research (1473) 1473
breast neoplasms - genetics (1405) 1405
breast neoplasms - mortality (1401) 1401
receptors, estrogen - metabolism (1387) 1387
antineoplastic agents - therapeutic use (1369) 1369
breast neoplasms - surgery (1352) 1352
health aspects (1351) 1351
postmenopause (1341) 1341
endocrine therapy (1334) 1334
aromatase inhibitors (1324) 1324
pharmacology & pharmacy (1315) 1315
medicine & public health (1309) 1309
risk factors (1290) 1290
aromatase inhibitors - therapeutic use (1238) 1238
breast neoplasms - therapy (1183) 1183
breast-cancer (1183) 1183
breast neoplasms - prevention & control (1181) 1181
analysis (1180) 1180
mice (1168) 1168
combined modality therapy (1150) 1150
estrogen antagonists - therapeutic use (1142) 1142
expression (1129) 1129
randomized-trial (1077) 1077
menopause (1044) 1044
disease-free survival (1021) 1021
obstetrics & gynecology (1012) 1012
prevention (1008) 1008
clinical trials as topic (999) 999
follow-up studies (996) 996
neoplasm staging (989) 989
drug therapy (983) 983
receptors, estrogen - analysis (959) 959
estrogen-receptor (953) 953
anastrozole (939) 939
antineoplastic agents, hormonal - adverse effects (926) 926
cell line, tumor (920) 920
time factors (904) 904
selective estrogen receptor modulators - therapeutic use (892) 892
tumors (876) 876
rats (866) 866
risk (866) 866
letrozole (862) 862
carcinoma (860) 860
surgery (841) 841
trial (830) 830
article (821) 821
triazoles - therapeutic use (813) 813
nitriles - therapeutic use (807) 807
retrospective studies (797) 797
randomized controlled trials as topic (786) 786
survival (770) 770
medicine, general & internal (769) 769
survival analysis (740) 740
apoptosis (723) 723
biochemistry & molecular biology (719) 719
endocrinology & metabolism (712) 712
skin and connective tissue diseases (687) 687
survival rate (679) 679
mastectomy (669) 669
cells (668) 668
gene expression (658) 658
adjuvant treatment (643) 643
immunohistochemistry (642) 642
tamoxifen - analogs & derivatives (640) 640
neoplasm metastasis (639) 639
research article (639) 639
antineoplastic agents, hormonal - pharmacology (626) 626
neoplasms, hormone-dependent - drug therapy (626) 626
drug resistance, neoplasm (603) 603
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15806) 15806
French (257) 257
Japanese (242) 242
German (192) 192
Russian (75) 75
Italian (69) 69
Spanish (51) 51
Chinese (50) 50
Polish (26) 26
Czech (16) 16
Dutch (16) 16
Hungarian (16) 16
Portuguese (13) 13
Danish (12) 12
Hebrew (9) 9
Bulgarian (7) 7
Korean (5) 5
Norwegian (5) 5
Finnish (4) 4
Romanian (4) 4
Swedish (4) 4
Bosnian (2) 2
Croatian (2) 2
Serbian (2) 2
Icelandic (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 496 - 503
Summary In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and... 
Hematology, Oncology and Palliative Medicine | ZOLEDRONIC ACID | SURGICAL ADJUVANT BREAST | ONCOLOGY | STATIN USE | LOW-DOSE TAMOXIFEN | RANDOMIZED-TRIAL | FOLLOW-UP | RISK | BOWEL PROJECT | POSTMENOPAUSAL WOMEN | GENOME-WIDE ASSOCIATION | Thiophenes - therapeutic use | Metformin - therapeutic use | Raloxifene Hydrochloride - therapeutic use | Humans | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Pyrrolidines - therapeutic use | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Estrogen Receptor Modulators - therapeutic use | Retinoids - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Female | Aromatase Inhibitors - therapeutic use | Estrogen Receptor Modulators - adverse effects | Anticarcinogenic Agents - therapeutic use | Triazoles - therapeutic use | Premenopause | Anastrozole | Consensus Development Conferences as Topic | Breast Neoplasms - prevention & control | Fenretinide - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Androstadienes - therapeutic use | Expert Testimony | Norpregnenes - therapeutic use | Nitriles - therapeutic use | COX-2 inhibitors | Care and treatment | Aspirin | Oncology, Experimental | Menopause | Phosphonates | Breast cancer | Retinoids | Research | Tamoxifen | Prevention | Analysis | Health aspects | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 7, pp. 679 - 691
This large trial tested the effect of adding zoledronic acid to adjuvant endocrine treatment (goserelin plus tamoxifen or anastrozole) in premenopausal women... 
RECEIVING ADJUVANT LETROZOLE | MULTIPLE-MYELOMA | OVARIAN ABLATION | BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS | MEDICINE, GENERAL & INTERNAL | BONE LOSS | SOLID TUMORS | TAMOXIFEN | DELTA-T-CELLS | POSTMENOPAUSAL WOMEN | AUSTRIAN BREAST | Breast Neoplasms - surgery | Triazoles - adverse effects | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Chemotherapy, Adjuvant | Imidazoles - therapeutic use | Drug Therapy, Combination | Goserelin - therapeutic use | Aromatase Inhibitors - therapeutic use | Diphosphonates - adverse effects | Triazoles - therapeutic use | Bone Density Conservation Agents - adverse effects | Premenopause | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Estrogen Antagonists - adverse effects | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Zoledronic acid | Care and treatment | Usage | Breast cancer | Health aspects | Function tests (Medicine) | Chemotherapy | Acids | Womens health | Menopause | Colorectal cancer | Cytotoxicity | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
by Lin, X and Huang, T
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 07/2016, Volume 30, Issue 7, pp. 1085 - 1091
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 7, pp. 631 - 641
Journal Article
Breast Cancer Research, ISSN 1465-5411, 01/2014, Volume 16, Issue 1, pp. R7 - R7
Journal Article
2002, 1., Cancer Drug Discovery and Development, ISBN 0896036731, xiv, 420
Book
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 12/2016, Volume 2016, Issue 12, p. CD002249
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 2, pp. 107 - 118
Journal Article